Astrana Health, Inc. provided earnings guidance for the year ending December 31, 2024. For the year, the company expects total revenue in the range of $1,650.0 million to $1,850.0 million, Net income attributable to Astrana Health, Inc. in the range of $61.0 million to $73.0 million and EPS ? diluted in the range of $1.28 to $1.52.
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
37.7 USD | +2.66% | +0.13% | -2.14% |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-2.14% | 1.77B | |
-14.80% | 84.68B | |
+14.74% | 81.12B | |
+10.49% | 29.59B | |
-10.05% | 16.73B | |
-1.39% | 16.36B | |
-31.58% | 11.77B | |
+1.82% | 11.72B | |
+31.67% | 11.71B | |
-0.47% | 11.66B |
- Stock Market
- Equities
- ASTH Stock
- News Astrana Health, Inc.
- Astrana Health, Inc. Provides Earnings Guidance for the Year Ending December 31, 2024